NCT07560683

Brief Summary

This study aims to investigate skin barrier function in intensive care unit (ICU) patients using biosensor-based measurements. Biophysical parameters including transepidermal water loss (TEWL), skin pH, stratum corneum hydration, local skin temperature, and sebum will be assessed in anatomical regions at risk for pressure injuries. The study will examine temporal changes in these parameters, their interrelationships, and their association with pressure injury development.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P50-P75 for all trials

Timeline
27mo left

Started Jul 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 21, 2026

Last Update Submit

April 28, 2026

Conditions

Keywords

barrier function of skinpressure-prone skin areaspressure injuryintensive care unitbiosensoryskin integrity

Outcome Measures

Primary Outcomes (1)

  • Change in transepidermal water loss (TEWL) in pressure injury-prone anatomical regions

    Transepidermal water loss (TEWL) values measured using a non-invasive biosensor device in pressure injury-prone anatomical regions, including the sacrum, right and left trochanters, right and left lateral legs, right and left scapulae, and posterior neck. TEWL will be evaluated longitudinally to determine temporal changes in skin barrier function and its association with pressure injury development.

    From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.

Secondary Outcomes (3)

  • Change in skin surface pH in pressure injury-prone anatomical regions

    From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.

  • Change in local skin temperature in pressure injury-prone anatomical regions

    From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.

  • Incidence of pressure injury during ICU stay

    Daily from baseline through Day 13 (or until ICU discharge, whichever occurs first)

Study Arms (2)

Cohort 1: Patients Without Pressure Injury

ICU patients who do not develop pressure injuries during the follow-up period. Skin barrier function parameters (TEWL, pH, stratum corneum hydration, local skin temperature) will be measured longitudinally in pressure injury-prone anatomical regions.

Cohort 2: Patients With Pressure Injury

ICU patients who develop pressure injuries during the follow-up period. Skin barrier function parameters will be assessed in both pressure injury-prone regions and adjacent intact skin areas to evaluate changes associated with pressure injury development.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult critically ill patients admitted to the intensive care unit (ICU) and at risk for pressure injury development will be enrolled. Participants will undergo longitudinal, non-invasive biosensor-based assessments of skin barrier function in pressure injury-prone anatomical regions throughout their ICU stay. The population will include both patients who develop pressure injuries and those who do not.

You may qualify if:

  • Adults aged \>18 years
  • Admission to the intensive care unit
  • Initial skin assessment completed within the first 4 hours after ICU admission
  • Hemodynamically stable enough to undergo follow-up and repeated skin measurements
  • Intact skin integrity at ICU admission
  • Willingness to participate in the study, with informed consent provided by the participant or legally authorized representative

You may not qualify if:

  • Inability to tolerate position changes
  • Post-cardiopulmonary resuscitation care period at enrollment
  • Cardiac arrest or cardiopulmonary resuscitation during follow-up
  • Severe edema or subcutaneous fluid accumulation
  • Presence of skin lesions before ICU admission
  • Systemic dermatologic disease directly affecting skin barrier function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University

Istanbul, 34000, Turkey (Türkiye)

Location

Related Publications (4)

  • McEvoy NL, Patton D, Curley GF, Moore Z. Pressure ulcer risk assessment in the ICU. Is it time for a more objective measure? Intensive Crit Care Nurs. 2024 Aug;83:103681. doi: 10.1016/j.iccn.2024.103681. Epub 2024 Mar 21.

    PMID: 38518456BACKGROUND
  • Abiakam NS, Jayabal H, Filingeri D, Bader DL, Worsley PR. Spatial and temporal changes in biophysical skin parameters over a category I pressure ulcer. Int Wound J. 2023 Oct;20(8):3164-3176. doi: 10.1111/iwj.14194. Epub 2023 Apr 14.

    PMID: 37060199BACKGROUND
  • Bader DL, Worsley PR. Technologies to monitor the health of loaded skin tissues. Biomed Eng Online. 2018 Apr 12;17(1):40. doi: 10.1186/s12938-018-0470-z.

    PMID: 29650012BACKGROUND
  • Akdeniz M, Gabriel S, Lichterfeld-Kottner A, Blume-Peytavi U, Kottner J. Transepidermal water loss in healthy adults: a systematic review and meta-analysis update. Br J Dermatol. 2018 Nov;179(5):1049-1055. doi: 10.1111/bjd.17025. Epub 2018 Sep 9.

    PMID: 30022486BACKGROUND

MeSH Terms

Conditions

Pressure UlcerSkin Abnormalities

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

TUĞBA ERDEM, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2026

First Posted

May 1, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

May 1, 2026

Record last verified: 2026-04

Locations